AMA: FDA action on OTC naloxone will save people from overdoses

| 1 Min Read

Statement attributable to:
Patrice A. Harris, MD, MA
President-elect, chair of the AMA Opioid Task Force
American Medical Association

“The AMA applauds the FDA and Commissioner Gottlieb for today’s action to provide labeling that would allow for over-the-counter availability of naloxone, a move that will save people from opioid-related overdose. Naloxone has saved tens of thousands of lives, and the AMA continues to strongly urge physicians to co-prescribe naloxone to patients at risk of opioid-related overdose.

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Stethoscope, glasses, pen and paper

2027 proposed Medicare fee schedule: What physicians need to know

| 11 Min Read
Healthcare worker places bandage on smiling patient

Doctors united on respiratory virus vaccine recommendations

| 10 Min Read
Couple looks at a tablet

Bill would put an end to yearly patches on Medicare physician pay

| 7 Min Read
Smiling patient listens to doctor

Better handoffs help home care cut hospital readmissions

| 6 Min Read